All posts

Calian Group is a Top Pick, says Echelon

It’s full speed ahead for Calian Group (Calian Group Stock Quote, Charts, News, Analysts, Financials TSX:CGY), according to Echelon Capital Markets analyst Amr Ezzat, who on Tuesday reiterated Calian as one of his Top Picks. Ezzat said Calian’s solid balance sheet and strong cash flow generation mark it as a good bet to deliver higher earnings in 2023.

Calian is a provider of business and technology services in the areas of Health, IT, Learning and Advanced Technologies, with clients in industry and government in Canada as well as worldwide. Founded in 1982, Calian is headquartered in Ottawa and has over 3,000 employees globally.

The company has consistently driven up revenue in recent years, including its latest — fiscal 2022 for the year ended September 30, reported in November — which saw revenue up 12 per cent to $582 million and adjusted EBITDA up 27 per cent to $66 million. 

By segment, Calian’s ITCS business saw the strongest growth in fiscal 2022, going from $82.3 million to $173.0 million in revenue. The company’s Health business dropped to $167.1 million, Advanced Technologies came in at $150.4 million and Calian’s Learning segment had revenue of $91.7 million.

The market responded to the good news, driving Calian’s share price to a fourth quarter 2022 return of 19.9 per cent, outperforming the S&P/TSX Small Cap Index which rose by 8.4 per cent.

But Ezzat sees further upside from here, reiterating a “Buy” rating on CGY and 12-month target of $85.00 per share, which at press time represented a projected return of 29.0 per cent.

“Trading at a last 12 months 8.6 per cent free cash flow yield, we believe current valuation levels provide investors with an exceptional opportunity to consolidate a position in a quality operator with a solid track record of value creation,” Ezzat wrote.

“Recall, CGY recently delivered impressive FQ422 results, a recurring theme, which cements the Company’s reputation as a resilient, secular compounder. With an unlevered capital structure ($35.1 million in cash and no debt) in a buyer’s market, we expect 2023 to be a year of more aggressive capital allocation into M&A,” he said.

Ezzat estimated Calian has between $150 and $200 million in liquidity to potentially deploy in acquisitions, which would add $20-35 million in EBITDA against the company’s last 12 months EBITDA of $65.9 million.

Ezzat has estimated Calian’s revenue to go from $582.2 million in 2022 to $658.2 million in 2023, while EBITDA is expected to go from $65.9 million to $70.3 million.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: cgy
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

22 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

22 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

23 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago